About AID
Established in 2011, the Australian Infectious Diseases Research Centre is a multidisciplinary network based at The University of Queensland, and the Queensland Institute of Medical Research.
- About Us
- Research areas
- Investigators
- Professor Greg Anderson
- Dr Kathy Andrews (ARC Fellow)
- Associate Professor Sassan Asgari
- Professor Ross Barnard
- Dr. Scott Beatson (ARC Fellow)
- Professor Scott Bell (QHealth Research)
- Dr. Helle Bielefeldt-Ohmann
- Dr. Antje Blumenthal (Balzan Fellow)
- Professor Scott Burrows
- Dr Mark Butler
- Professor Robert Capon
- Professor Anne Chang (NHMRC Practitioner)
- Professor Archie Clements (NHMRC CDA)
- Rowland Cobbold
- Dr Jason Cole (NHMRC Training)
- Professor Matthew Cooper (NHMRC Aust)
- Professor Darrell Crawford
- Dr. Mark Davies (NHMRC Training)
- Professor Denise Doolan
- Professor David Fairlie (NHMRC SPRF)
- Dr Katja Fischer
- Dr. James Fraser
- Professor Ian Frazer
- Associate Professor Don Gardiner
- Dr Darren Gray - Australian Research Council Fellow (DECRA)
- Professor Keith Grimwood
- Professor Roy Hall
- Dr Ashraful Haque
- Professor Philip Hugenholtz (ARC DORA)
- Dr. Ulrike Kappler (ARC Fellow)
- Associate Professor Stuart Kellie
- Professor Mark Kendall (ARC Future)
- Professor Alexander Khromykh (NHMRC SRF)
- Professor Glenn King
- Professor Bostjan Kobe (NHMRC SRF)
- Dr Lutz Krause
- Associate Professor Stephen Lambert (NHMRC ECR)
- Professor Jeffrey Lipman
- Associate Professor Ian Mackay
- Professor Jenny Martin (ARC Laureate)
- Professor James McCarthy
- Professor Alastair McEwan
- Professor Don McManus
- Dr David McMillan
- Associate Professor Frederic Meunier (NHMRC SRF)
- Professor Anton Middelberg (Smart Futures Premier's)
- Professor Michael Monteiro (ARC Future)
- Dr. Michael Nissen
- Dr Kerry-Ann O'Grady
- Associate Professor Colleen Olive
- Professor David Paterson (NHMRC Practitioner)
- Dr Nico Petty
- Dr. Simon Phipps
- Dr. David Reid (NHMRC Practitioner)
- Professor Mark Schembri (ARC Future Fellow)
- Associate Professor Gary Schenk
- Professor Mark Ragan
- Dr. Kate Schroder (NHMRC CJ Martin Fellow)
- Dr. Ben Schulz (NHMRC CDA)
- Associate Professor Theo Sloots
- Professor Peter Sly (NHMRC SPRF)
- Dr. Kirsten Spann
- Professor Sri Sriprakash
- Dr. Kate Stacey (ARC Future)
- Jason Steen
- Professor Jenny Stow (NHMRC PRF)
- Dr. Matthew Sweet (ARC Future Fellow and Honorary NHMRC Senior Research Fellow)
- Professor Andreas Suhrbier
- Associate Professor Rohan Teasdale (NHMRC SRF)
- Professor Istvan Toth (ARC APF)
- Professor Matt Trau
- Dr Rebecca Traub
- Associate Professor Katharine Trenholme
- Associate Professor Claire Wainwright (QHealth Research)
- Professor Mark Walker (NHMRC PRF)
- Associate Professor Christine Wells (NHMRC CDA)
- Dr Nick West (NHMRC CDA2)
- Associate Professor David Whiley
- Professor Paul Young
- Brian Kay AM
- Professor Jeff Gorman
- Seminars
- Partners
- News and Events
- AID Researcher Ian Mackay discusses H7N9 flu in China
- Discovering novel ways to influence host/pathogen dynamics to favour microbial control and clearance of chronic overwhelming viral infections
- Seminars
- Members of our Research Centre hail potential cure for AIDS
- Tracking Superbugs to their source
- Development of a multicomponent delivery system for oligonucleotides
- AID member recieves Grand Challenges Explorations grant
- Research Seminars for 2012
- 2011: A good year for Infectious Diseases Research at UQ
- AID's Eureka Prize is announced
- New vaccine delivery company starts with AUD15 million investment
- AID researcher talks superbugs on Insight
- AID is officially launched
- AID Sponsors national prize
- Apply for the Australian Infectious Diseases Centre Eureka Prize for Infectious Diseases Research
- AID researchers awarded seven prestigious fellowships
- Funding
- Contact Us
Expected outcomes
AID will deliver:
• A world-class centre with capacity to undertake research on human infectious agents.
• Expanded collaborative networks for infectious disease research utilising cell biology, nanotechnology, protein biochemistry, molecular and structural biology expertise.
• Improved translational focus, with projects undertaken on diagnostics, vaccine development, design and application of new antimicrobials, and the design of novel therapeutics against microbial virulence determinants. AID will deliver translational outcomes that contribute to the Australian health system and economy.